THANK YOU FOR SUBSCRIBING


Ward Servaes, CEO and Co-founder, moveUPFive years since, the challenges have only aggravated. While the number of patients requiring total knee and hip replacement continues, meeting patient demands in a diminishing surgeon workforce has become a big hurdle. Statistically, in the OECD countries, especially in Europe, 140 arthroplasty surgeries are performed every 100,000 inhabitants, which is around 2 million cases per year, but up to 30 percent of patients end up dissatisfied, mostly because of the 15-20 percent incidence of the chronic pain. This happens due to the rise of high variability in the standard of care on the course of the pre- and post-surgery, despite the surgery being standardised itself. Additionally, the changes sweeping the healthcare industry has left many orthopaedic surgeons unsure of how to proceed.
Servaes and his batchmate realised that the application of digital technologies to enable mobile health, could not just tackle the issues the surgeon mentioned, but also bring in extra opportunities and value for the surgeon, patient and other stakeholders of the ecosystem. The duo co-founded moveUP to directly provide or let the healthcare professionals offer a hundred percent personalised treatment to every patient.
With an ardent focus on patient engagement, moveUP is an expert in digital therapeutics offering a whole range of patient pathway solutions through companion, coaching and live monitoring. “Our uniqueness lies in bringing digital therapeutics—all as a certified service or medical device,” says Servaes, CEO and co-founder of moveUP. The ISO 13485 certified company’s expertise stemmed from orthopaedics, specifically knee/hip replacement, while it is extending its offerings constantly. For each pathology, moveUP matches with a clear value proposition for each of the stakeholders (patient empowerment, specialists, physical therapists, GP, nurse) through industry partnerships. By continuously applying extensive research and evidence collection, the expert team at moveUP is committed to improving its platform to enable personalised digital therapeutics in orthopaedics and beyond. In doing so, the company leverages lean methodology, focus groups, quality management system and clinical studies to strengthen its value proposition in the market. “Since our internationalisation, with the help of data-driven decision-making, we can flexibly customise our services to the needs and possibilities and apply it to multiple healthcare systems,” adds Servaes.
![]()
Our uniqueness lies in bringing digital therapeutics—all as a certified service or medical device
Furthermore, in the wake of the global coronavirus pandemic, the demand for telehealth apps like moveUP has witnessed a sharp rise. To keep up with this demand, the company has launched a COVID-19 app and platform to support all the affected stakeholders. With this, moveUP offers a treatment to diagnose, triage and follow up for patients with COVID-19 symptoms. Alongside, an aggregated live dashboard allows constant monitoring of their status and progress. A patient with COVID symptoms can contact his GP and ask for hi COVID-moveUP code. With this code the doctor can immediately follow you up via the app. On the other hand, if a user cannot reach his GP for the COVID-moveUP code, a dedicated team of doctors can link him to his GP.
moveUP ensures that the treating surgeon is updated on the patient’s evolution through regular reports. The method of alerting the treating surgeon is old and cascading, with physical therapists and nurses in the first line of handling the majority of the care. They escalate an issue only in case of an emergency where the surgeon needs to be contacted. This frees the surgeon from having to perform daily checks on patients as they get constant alerts on the smartphone or website. The data-driven moveUP therapies system takes care of any issue until it becomes an emergency, allowing the surgeon to maintain his peace of mind. Additionally, as at each point, a clear report is available for every patient, the consultation is more optimised than the usual.
As moveUP looks to scale up, the company’s ISO certification has been instrumental in building and fortifying the clients’ trust. Besides ensuring efficiency with its product quality, moveUP also brings user satisfaction for the patient, surgeon, physical therapist, and every other stakeholder. Driven by Michael Porter’s value-based healthcare principles, moveUP reduces the number of dissatisfied patients and brings better results with lesser complications for the patients. Furthermore, backed by R&D partnerships with hospitals and universities, the company is currently developing data-driven machine learning models to enhance the efficiencies, outcome and patient satisfaction. When it comes to delivering world-class care to patients on a daily basis, the use of data can help surgeons, along with physical therapists and nurses to early-detect potential complications.
Moving ahead, moveUP is looking for flooding synergies with partners (industry/healthcare providers/funds) who can collaborate and invest in their innovation. With a scalable platform solution, the company has plans for an extension to domains and pathologies outside orthopaedics. “We will also extend the value that we bring in terms of patient insights, clinical decision-making, and high patient satisfaction, to other domains or types of treatments,” concludes Servaes.
Company
moveUP
Management
Ward Servaes, CEO and Co-founder, moveUP
Description
With an ardent focus on patient engagement, moveUP is an expert in digital therapeutics offering a whole range of patient pathway solutions through companion, coaching and live monitoring. The company brings digital therapeutics—all as a certified service or medical device. For each pathology, moveUP matches with a clear value proposition for each of the stakeholders (patient empowerment, specialists, physical therapists, GP, nurse) through industry partnerships. By continuously applying extensive research and evidence collection, the expert team at moveUP is committed to improving its platform to enable personalised digital therapeutics in orthopaedics and beyond. In doing so, the company leverages lean methodology, focus groups, quality management system and clinical studies to strengthen its value proposition in the market.